Biotechnology Startups in North Carolina

10 biotechnology companies in North Carolina that have filed with the SEC.

10Companies

Aer Therapeutics, Inc.

Biotechnology
Raleigh, North Carolina

Aer Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative therapies targeting mucus-related issues in lung diseases. The company's primary focus is on creating inhalable treatments to address airway mucus plugs, which are common in conditions like COPD and asthma.

Altis Biosystems, Inc.

Biotechnology
Durham, North Carolina

Altis Biosystems, Inc. is a pioneering biotechnology firm based in North Carolina, dedicated to enhancing preclinical research through the development of innovative human cell-based models that accurately replicate the gastrointestinal (GI) tract. By providing superior alternatives to traditional cell line and animal models, Altis facilitates improved drug discovery and development, ensuring better predictive insights and reducing reliance on animal testing.

BioPhoundry, Inc.

Biotechnology
Chapel Hill, North Carolina

BioPhoundry, Inc. is a pioneering biotechnology company that specializes in the development of advanced bioengineering solutions to address complex biological challenges. They are committed to driving innovation in the biotechnology sector through robust research and cutting-edge technology.

Founded 2024

Galaxy Diagnostics, Inc.

Biotechnology
Research Triangle Park, North Carolina

Galaxy Diagnostics, Inc. specializes in advanced testing solutions designed to detect elusive flea- and tick-borne pathogens, specifically *Bartonella* species, which are often missed by standard diagnostic methods. By enhancing clinical detection, the company aims to improve patient outcomes and strengthen the connection between human and animal health.

MASLOW HEALTH INC.

Biotechnology
Chapel Hill, North Carolina

MASLOW HEALTH INC. is a registered entity in the health sector, though specific details regarding its products and services are currently not available. The company appears to operate within the health and wellness subsector, focusing on innovative solutions for healthcare challenges. However, without further information, its unique value proposition remains undefined.

Founded 2023

OraLiva, Inc.

Biotechnology
Durham, North Carolina

OraLiva, Inc. is an innovative medical technology company specializing in the development of advanced early detection diagnostics for oral cancer. By leveraging cutting-edge technology, the company aims to address the critical issue of late-stage cancer diagnosis, enhancing patient outcomes through timely intervention.

Scorpius Holdings, Inc.

Biotechnology
Morrisville, North Carolina

Scorpius Holdings, Inc. is a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing through its subsidiary, Scorpius BioManufacturing. Based in Morrisville, North Carolina, with facilities in San Antonio, Texas, the company provides comprehensive services including process development and analytical testing to pharmaceutical and biotech companies.

Surgical Training Simulators, Inc.

Biotechnology
Chapel Hill, North Carolina

Surgical Training Simulators, Inc. is dedicated to enhancing surgical education through innovative technology. The company specializes in developing advanced virtual reality surgical simulators that provide a realistic training environment, ensuring that surgical trainees can hone their skills safely and effectively without risking patient safety.

Founded 2024

VQ Biomedical, Inc.

Biotechnology
Apex, North Carolina

VQ Biomedical, Inc. is a pioneering medical device company specializing in advanced healthcare solutions for patients suffering from acute respiratory distress syndrome (ARDS) and other severe lung injuries. By developing innovative technologies, the company aims to improve patient outcomes and enhance the quality of care provided in critical health situations.

Founded 2023

Xilis, Inc.

Biotechnology
Durham, North Carolina

Xilis, Inc. is a biotech company focused on transforming cancer treatment through innovative technologies that enable personalized medicine. By leveraging its proprietary MicroOrganoSphere™ technology, Xilis offers tailored therapeutic solutions that match cancer patients with the most effective treatments based on their individual tumor biology.